Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sphere Medical Holding

Request full access

Patient-connected critical care blood gas monitoring systems

Cambridge, United KingdomFounded 2002Biotech & Life Sciences

About Sphere Medical Holding

Sphere Medical Holding PLC was a medical device company that developed, manufactured, and sold monitoring products for critical care environments. Incorporated in 2001 and based in Cambridge, UK, the company focused on creating diagnostic equipment for the near-real-time measurement of blood gases, electrolytes, and metabolites. The company's operations ceased as of December 30, 2021.

The company's flagship product was the Proxima platform, a patient-dedicated blood gas analyser designed for use in intensive care units (ICU) and operating rooms. The system integrated directly into the patient's arterial line, providing rapid analysis at the bedside. This ex-vivo, closed-loop system drew a blood sample, analyzed it with a miniaturized sensor, and returned the blood to the patient, minimizing blood loss and infection risk. The Proxima system aimed to enable faster clinical decision-making and improve patient outcomes by providing continuous data without leaving the patient's side. Over its lifecycle, Sphere Medical launched successive generations of the product, including Proxima 3 and Proxima 4, with the latter expanding the analyte panel and adding usability for certain pediatric patients.

Sphere Medical operated through a direct sales force in the UK, Germany, the Netherlands, and Belgium, and utilized distributors in other markets like Italy and Spain. The company's business model was centered on the commercialization of its Proxima platform, generating revenue from the sale of the bedside monitors and disposable sensors. Despite securing CE Mark approval for its products and expanding its commercial reach into Europe, the company ultimately went out of business.

Source: Dealroom company data

At a glance

Status
Listed
Listing
IPO 2011
Open positions
None listed
Dealroom signal
29.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Testing, Biotechnology, Hard Tech, medical testing, DT and LS, uk is8 life sciences, science-based
Technology
Hardware
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
POST IPO EQUITY✓Other financing Apr 2015 $17M — Arthurian Life Sciences · Parkwalk Advisors —
IPO✓Exit Nov 2011 $0 — Undisclosed ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearProfitMargin
2026 −$1.8M —
2025 −$1.8M —
2024 −$1.8M —
2023 —
2022 —
2021 —
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Sphere Medical Holding website traffic

Latest recorded traffic for Sphere Medical Holding is 100 monthly website visits, down 37.5% over the last three months.

Latest monthly visits100 3-month web change-37.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Sphere Medical Holding in the Cambridge ecosystem

Live from Dealroom

The Sphere Medical Holding office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later2 investors entered at this stage

  • Arthurian Life Sciences
  • Parkwalk Advisors

Other known investors1 additional known investor

  • University of Bristol Enterprise Fund
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇬🇧 United Kingdom · Cambridge HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sphere Medical Holding on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sphere Medical Holding’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.